The Pep Talk LL37 Protects Against COVID Infection + Inside Tracker Review’s Carl's Blood Work

Guest: Jean-François Tremblay - Ashley Reaver

A recent multi-center study from Shenzhen and Shanghai China showed that the human cathelicidin LL37 provides protection against SARS-Cov-2 in 2 ways. It blocks the spike protein and Cloaks the ACE2 receptor. This dual-action Makes LL37 a strong player in both the prevention and therapy treating the COVID Infection. We discuss the implications of this study against the Current backdrop of available treatments. PLUS Carl reviews his Current blood work with an Inside Tracker advisor to see how he’s holding up at 63 years old, and what he Can do differently to improve his healthy aging.